MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced financial results for the third quarter fiscal year 2015 ended January 31, 2015.
Help employers find you! Check out all the jobs and post your resume.
